Emerging Clinical Data on GLP-1 Receptor Agonists in Alcohol Use Disorder
Comments Off on Emerging Clinical Data on GLP-1 Receptor Agonists in Alcohol Use Disorder
June 2, 2026
GLP-1 receptor agonist alcohol use disorder clinical data reveals potential therapeutic effects beyond glycemic control. This emerging evidence suggests benefits in craving reduction and reward pathway modulation. Family medicine clinicians should…
Clinical Evidence on Semaglutide for Alcohol Consumption Reduction
Comments Off on Clinical Evidence on Semaglutide for Alcohol Consumption Reduction
May 10, 2026
Semaglutide alcohol consumption reduction shows promise in clinical trials for patients with alcohol use disorder. This GLP-1 receptor agonist may help reduce heavy drinking days and overall alcohol intake. Understanding this effect is important for…